← Back to headlines
DiaMedica Therapeutics Reports GAAP EPS of -$0.70, Missing Estimates
DiaMedica Therapeutics announced its GAAP Earnings Per Share (EPS) for the latest period was -$0.70, missing analyst estimates by $0.02, with further details released in their financial report.
30 Mar, 20:47 — 30 Mar, 20:47
Sources
Showing 1 of 1 sources
Related Stories
Indian Markets Close at Two-Year Low, Rupee Breaches 95 Amid US-Iran Tensions
16m ago
US Investigators Probe Insider Trading on Iran Conflict Prediction Markets, Broker's Pre-Attack Investment Explored
23m ago
Lantern Pharma Projects $15B–$20B Market Potential Amid AI Pipeline Advancement
23m ago
U.S. Crude Oil Surpasses $100 Amid Middle East Tensions
30m ago